rxstat › Classes › Antiinflammatory/antirheumatic Prod.,non-steroids

Antiinflammatory/antirheumatic Prod.,non-steroids: shortage status in Canada

9 of the 16 antiinflammatory/antirheumatic prod.,non-steroids rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Esomeprazole Naproxen (Vimovo) Widespread shortage 2 of 3 reported products affected · est. return Nov 24, 2026 Tiaprofenic Acid Widespread shortage 2 of 4 reported products affected Celecoxib (Celebrex) Partial shortage 1 of 31 reported products affected Diclofenac (Voltaren Rapide) Partial shortage 2 of 7 reported products affected · est. return Jul 31, 2026 Ibuprofen (Novo-Profen) Partial shortage 2 of 14 reported products affected Indomethacin Partial shortage 3 of 7 reported products affected · est. return Oct 10, 2026 Naproxen (Naprosyn) Partial shortage 7 of 29 reported products affected · est. return Sep 11, 2026 Naproxen Partial shortage 1 of 8 reported products affected Oxaprozin Partial shortage 1 of 1 reported products affected Etodolac Discontinued 0 of 2 reported products affected Ketoprofen Discontinued 0 of 6 reported products affected Mefenamic Acid (Ponstan) Discontinued 0 of 2 reported products affected Misoprostol Diclofenac (Arthrotec) No current shortage Piroxicam No current shortage Sulindac No current shortage Tenoxicam Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.